Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience.

about

Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience.

Item

http://www.wikidata.org/entity/Q36569874

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Fungal pathogens and primary a ...... gnancies: one year experience.

@ast

Fungal pathogens and primary a ...... gnancies: one year experience.

@en

type

Item

label

Fungal pathogens and primary a ...... gnancies: one year experience.

@ast

Fungal pathogens and primary a ...... gnancies: one year experience.

@en

prefLabel

Fungal pathogens and primary a ...... gnancies: one year experience.

@ast

Fungal pathogens and primary a ...... gnancies: one year experience.

@en

P1476

Fungal pathogens and primary a ...... gnancies: one year experience.

@en

P2093

D Arica

http://www.w3.org/2001/XMLSchema#string

D Aydin

http://www.w3.org/2001/XMLSchema#string

F Simsek

http://www.w3.org/2001/XMLSchema#string

H Gedik

http://www.w3.org/2001/XMLSchema#string

M T Yildirmak

http://www.w3.org/2001/XMLSchema#string

N Demirel

http://www.w3.org/2001/XMLSchema#string

O Yokus

http://www.w3.org/2001/XMLSchema#string

P2860

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Management of febrile neutropenia: ESMO Clinical Practice Guidelines.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.

Fungal infections in patients with acute leukemia.

P304

390-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23382758

http://www.w3.org/2001/XMLSchema#string

P932

3557695

http://www.w3.org/2001/XMLSchema#string